Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

648
Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
648
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

857
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
857
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

592
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
592
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

3.4K
Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
3.4K
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

2.6K
Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart...
2.6K
The Cardiac Cycle01:13

The Cardiac Cycle

98.2K
The heart beats rhythmically in a sequence called the cardiac cycle—a rapid coordination of contraction (systole) and relaxation (diastole).
The Process
Electrical signals—sent from the sinoatrial (SA) node in the right atrial wall to the atrioventricular (AV) node between the right atrium and right ventricle—cause both atria to simultaneously contract. When the signal reaches the AV node, it pauses for approximately a tenth of a second, allowing the atria to contract and...
98.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revisiting the obesity paradox in patients with heart failure with reduced ejection fraction in the light of contemporary guideline-directed medical therapy.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

[Prevalence of ECG abnormalities in hypertrophic cardiomyopathy: who seeks will find].

Orvosi hetilap·2025
Same author

Eligibility for Rapid Up-Titration of Guideline-Directed Medical Therapy of Real-World Patients Hospitalised for Heart Failure.

Cardiology·2025
Same author

Therapeutic Consequences and Prognostic Impact of Multimorbidity in Heart Failure: Time to Act.

Journal of clinical medicine·2025
Same author

[The role of complex patient education program in heart failure care].

Orvosi hetilap·2024
Same author

[Rapid up-titration of guide-directed medical therapy after a heart failure hospitalisation].

Orvosi hetilap·2024

Related Experiment Video

Updated: Feb 1, 2026

Transthoracic Echocardiography in Mice
08:09

Transthoracic Echocardiography in Mice

Published on: May 28, 2010

64.5K

Cardiac Index by Transthoracic Echocardiography (CITE) study.

Barna Szabó1, Eszter Krisztina Marosi1, Katarina Vargová1

  • 1Heart-Lung-Physiology Clinic, Örebro University Hospital, Örebro, Sweden.

Plos One
|December 13, 2018
PubMed
Summary

Cardiac index (CI) shows potential as an alternative to left ventricular ejection fraction (LVEF) for predicting heart failure readmission, especially in patients without reduced LVEF. Both measures offer similar predictive accuracy for mortality and readmission in heart failure patients.

More Related Videos

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

3.5K
Transthoracic Speckle Tracking Echocardiography for the Quantitative Assessment of Left Ventricular Myocardial Deformation
09:05

Transthoracic Speckle Tracking Echocardiography for the Quantitative Assessment of Left Ventricular Myocardial Deformation

Published on: October 20, 2016

20.1K

Related Experiment Videos

Last Updated: Feb 1, 2026

Transthoracic Echocardiography in Mice
08:09

Transthoracic Echocardiography in Mice

Published on: May 28, 2010

64.5K
Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

3.5K
Transthoracic Speckle Tracking Echocardiography for the Quantitative Assessment of Left Ventricular Myocardial Deformation
09:05

Transthoracic Speckle Tracking Echocardiography for the Quantitative Assessment of Left Ventricular Myocardial Deformation

Published on: October 20, 2016

20.1K

Area of Science:

  • Cardiology
  • Echocardiography
  • Heart Failure Research

Background:

  • Left ventricular ejection fraction (LVEF) is the standard metric for heart failure (HF) assessment.
  • Cardiac index (CI) is emerging as a potential alternative, but requires further validation.

Purpose of the Study:

  • To compare the predictive accuracy of LVEF and echocardiographically-derived CI in hospitalized HF patients.
  • To evaluate their roles in predicting mortality and HF readmission.

Main Methods:

  • Retrospective cohort study of 334 acute HF patients (2010-2016).
  • Cox proportional hazard models used to assess LVEF and CI for predicting all-cause death, CV death, and HF readmission.

Main Results:

  • CI predicted HF readmission in the overall cohort, while LVEF did not correlate with any endpoint.
  • LVEF predicted CV mortality in HF with reduced LVEF (HFrEF) patients.
  • CI predicted HF readmission in non-HFrEF patients.

Conclusions:

  • CI may serve as a valuable alternative to LVEF for assessing cardiac function, particularly in HF patients with midrange or preserved LVEF.
  • Both LVEF and CI models demonstrated comparable predictive accuracy for mortality and HF readmission.
  • CI shows promise as a new tool for managing HF patients.